Andrew R. Green
Novartis (Switzerland)(CH)Nottingham University Hospitals NHS Trust(GB)University of Ulster(GB)University of Nottingham(GB)King's College London(GB)Breast Cancer Research Foundation(US)Nottingham City Hospital(GB)Northumbria University(GB)Estación Biológica de Doñana(ES)Novartis (China)(CN)University of KwaZulu-Natal(ZA)Rivers State University(NG)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Cancer-related Molecular Pathways
Most-Cited Works
- → The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups(2012)6,273 cited
- → Differential oestrogen receptor binding is associated with clinical outcome in breast cancer(2012)2,322 cited
- → The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes(2016)1,777 cited
- → Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer(2011)1,365 cited
- → Prognostic markers in triple‐negative breast cancer(2006)1,276 cited
- → Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies(2010)1,150 cited